Michal Mielcarek

Michal Mielcarek

Imperial College London

H-index: 22

Europe-United Kingdom

About Michal Mielcarek

Michal Mielcarek, With an exceptional h-index of 22 and a recent h-index of 16 (since 2020), a distinguished researcher at Imperial College London, specializes in the field of Neurodegeneration.

His recent articles reflect a diverse array of research interests and contributions to the field:

Deregulated Transcriptome as a Platform for Adrenal Huntington’s Disease-Related Pathology

Therapeutic nucleic acids, peptides and uses ii

A minimal region of the HSP90AB1 promoter is suitable for ubiquitous expression in different somatic tissues with applicability for gene therapy

Active delivery of nucleic acids and peptides, methods and uses

Identification of the transcriptional biomarkers panel linked to pathological remodelling of the eye tissues in various HD mouse models

Structural abnormalities of the optic nerve and retina in Huntington’s disease pre-clinical and clinical settings

Gene therapy advances: a meta-analysis of AAV usage in clinical settings

Kinetin stimulates differentiation of C2C12 myoblasts

Michal Mielcarek Information

University

Position

___

Citations(all)

1645

Citations(since 2020)

820

Cited By

1132

hIndex(all)

22

hIndex(since 2020)

16

i10Index(all)

27

i10Index(since 2020)

23

Email

University Profile Page

Imperial College London

Google Scholar

View Google Scholar Profile

Michal Mielcarek Skills & Research Interests

Neurodegeneration

Top articles of Michal Mielcarek

Title

Journal

Author(s)

Publication Date

Deregulated Transcriptome as a Platform for Adrenal Huntington’s Disease-Related Pathology

International Journal of Molecular Sciences

Anna Olechnowicz

Małgorzata Blatkiewicz

Karol Jopek

Mark Isalan

Michal Mielcarek

...

2024/2/11

Therapeutic nucleic acids, peptides and uses ii

2023/8/31

A minimal region of the HSP90AB1 promoter is suitable for ubiquitous expression in different somatic tissues with applicability for gene therapy

Frontiers in Molecular Biosciences

Michal Mielcarek

Mark Isalan

2023/4/17

Active delivery of nucleic acids and peptides, methods and uses

2023/8/31

Identification of the transcriptional biomarkers panel linked to pathological remodelling of the eye tissues in various HD mouse models

Cells

Iwona Mazur-Michałek

Marcin Ruciński

Mateusz Sowiński

Paulina Pietras

Marta Leśniczak-Staszak

...

2022/5/18

Structural abnormalities of the optic nerve and retina in Huntington’s disease pre-clinical and clinical settings

International journal of molecular sciences

Iwona Mazur-Michałek

Katarzyna Kowalska

Daniel Zielonka

Marta Leśniczak-Staszak

Paulina Pietras

...

2022/5/13

Gene therapy advances: a meta-analysis of AAV usage in clinical settings

Hau Kiu Edna Au

Mark Isalan

Michal Mielcarek

2022/2/9

Kinetin stimulates differentiation of C2C12 myoblasts

PLoS One

Michal Mielcarek

Mark Isalan

2021/10/13

聚谷氨酰胺疾病: 超越神经退行变宇宙

中国神经再生研究 (英文版)

Michal Mielcarek

Mark Isalan

2021/6/15

Polyglutamine diseases: Looking beyond the neurodegenerative universe

Neural Regeneration Research

Michal Mielcarek

Mark Isalan

2021/6/1

Cross-sectional transcriptional analysis of the aging murine heart

Frontiers in Molecular Biosciences

Matthew Greenig

Andrew Melville

Derek Huntley

Mark Isalan

Michal Mielcarek

2020/9/25

Prevalence of non-psychiatric comorbidities in pre-symptomatic and symptomatic Huntington's disease gene carriers in Poland

Frontiers in Medicine

Daniel Zielonka

Grzegorz Witkowski

Elzbieta A Puch

Marta Lesniczak

Iwona Mazur-Michalek

...

2020/3/11

See List of Professors in Michal Mielcarek University(Imperial College London)